Linked from

The 55 pages that link to Newborn screening, each with the reason it gives.

• Genetic counselingRelated: A positive screen may prompt confirmatory testing and family counseling.

• Genetic testingBroader topic: It applies population-level genetic and biochemical testing shortly after birth.

• Autosomal recessive inheritanceRelated: Some recessive conditions are screened for before symptoms appear.

• Cystic fibrosisRelated: Early detection of cystic fibrosis enables timely nutritional support and specialist care.

• Personalized medicineRelated: Screening can identify inherited conditions before symptoms appear.

• Congenital anomalyCompared with: It targets many functional and metabolic disorders, rather than structural anomalies alone.

• Sickle cell diseaseRelated: Early detection enables preventive care before sickle cell complications emerge.

• Congenital disorderRelated: Screening detects certain functional disorders that may not be visible at birth.

• Next-generation sequencingRelated: Sequencing can identify genetic causes when standard screening tests are inconclusive.

• Congenital adrenal hyperplasiaRelated: Screening programs can detect classic 21-hydroxylase deficiency before a salt-wasting crisis.

• Enzyme replacement therapyRelated: Earlier diagnosis can allow treatment before irreversible organ damage develops.

• Rare diseaseRelated: Screening can prevent harm from rare conditions that are difficult to recognize clinically.

• Carrier screeningCompared with: Unlike carrier screening, it seeks affected infants rather than unaffected carriers.

• PediatricsRelated: Early detection can prevent severe outcomes for treatable congenital and metabolic disorders.

• PhenylalanineRelated: Screening commonly detects phenylketonuria before phenylalanine accumulation causes severe harm.

• PhenylketonuriaRelated: Early detection allows treatment before phenylalanine damages the developing brain.

• Severe combined immunodeficiencyRelated: Screening for low T-cell receptor excision circles can identify SCID before infections begin.

• Genetic disorderRelated: Screening detects some genetic disorders before symptoms appear.

• Lysosomal storage diseaseRelated: Screening programs can detect certain lysosomal diseases before irreversible damage develops.

• Molecular genetic testingRelated: Some screening programs use molecular tests to detect disease-associated variants.

• Medical geneticsRelated: It identifies treatable genetic disorders before symptoms appear.

• Spinal muscular atrophyRelated: Early identification allows treatment before extensive motor-neuron loss.

• Vertical transmissionRelated: Some infections are detected after birth so treatment can begin before symptoms worsen.

• DiGeorge syndromeRelated: Newborn T-cell screening can reveal severe immune deficiency associated with thymic underdevelopment.

• LeukodystrophyRelated: Screening for X-linked adrenoleukodystrophy can enable surveillance and early treatment.

• Molecular diagnosticsRelated: Some screening programs use molecular assays to detect disease-associated variants.

• Neonatal jaundiceRelated: Bilirubin assessment before discharge helps detect infants needing follow-up or treatment.

• Gaucher diseaseRelated: Early diagnosis can identify affected infants before severe manifestations develop.

• Genetic screeningBroader topic: It is a widely established population-based application of genetic screening.

• Glycogen storage diseaseRelated: Screening can detect Pompe disease before severe symptoms develop.

• HomocysteineRelated: Some screening programs detect metabolic disorders that cause marked homocysteine accumulation.

• HomocystinuriaRelated: Screening can detect some forms before irreversible complications develop.

• Tay–Sachs diseaseRelated: Screening programs can identify Tay–Sachs in some regions, enabling early follow-up.

• Birth defectRelated: It detects some congenital functional disorders that prenatal imaging cannot show.

• Krabbe diseaseRelated: Screening can identify low GALC activity before symptoms appear, though follow-up is essential.

• Maple syrup urine diseaseRelated: Screening can identify affected infants before a first metabolic crisis.

• Metachromatic leukodystrophyRelated: Screening programs can identify affected infants before neurological decline becomes apparent.

• AdrenoleukodystrophyRelated: Screening can identify affected boys before symptoms appear, allowing surveillance and timely evaluation.

• Canavan diseaseRelated: Canavan disease can be detected through programs screening for elevated N-acetylaspartic acid.

• GalactosemiaRelated: Screening can identify galactosemia before symptoms become severe.

• Glutaric acidRelated: Screening can detect metabolic markers associated with impaired glutaric-acid breakdown.

• IsoleucineRelated: Blood tests can detect elevated branched-chain amino acids associated with maple syrup urine disease.

• NeonatologyRelated: Screening identifies certain serious conditions before symptoms become apparent.

• Medical laboratoryRelated: Laboratory screening can enable early treatment of certain inherited or metabolic disorders.

• Menkes diseaseRelated: Screening approaches could identify affected infants before symptoms make the diagnosis apparent.

• Metabolic disorderRelated: Screening can detect treatable inherited metabolic disorders early.

• Barth syndromeRelated: In some regions, an abnormal cardiolipin-related marker can prompt testing for Barth syndrome.

• Combined malonic and methylmalonic aciduriaRelated: Biochemical findings may prompt follow-up testing after an abnormal screening result.

• Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesRelated: Screening targets some inherited and neonatal diseases covered by the category.

• Glycogen storage disease type IIRelated: Early identification of Pompe disease allows treatment before severe damage develops.